Director Chen Xiaobei, a leading refractive surgery expert, was invited to attend the HORIZON 2026 Asia-Pacific Ophthalmology Summit. She delivered an in-depth sharing on the new-generation SMILE technology and received an honorary award.

From April 18 to 19, 2026, the ZEISS Asia-Pacific Ophthalmology Summit (HORIZON 2026) was grandly held in Shanghai. The event gathered top experts and scholars in the field of refractive surgery across the Asia-Pacific region to jointly explore technological innovations, clinical applications and emerging industry trends in refractive surgery. It marked the first anniversary of the official launch of the new-generation robotic ReLEx SMILE™️ VISUMAX 800 in China. Nationwide installations have exceeded 120 units, and the total number of new-generation robotic SMILE pro procedures performed across the country has surpassed 80,000. With remarkable industry momentum, a new chapter of high-quality development has been written for China’s refractive surgery sector.

Director Chen Xiaobei from the Refractive Surgery Department of Aier Eye Hospital Dongguan, together with key physician Dr. Sun Xiaoxue, attended the summit as distinguished guests. They took an active part in in-depth academic exchanges throughout the conference and were invited to deliver a keynote speech at the special SMILE pro Seminar. Sharing in-depth clinical research achievements and exchanging insights on cutting-edge technologies with local practical experience, they fully demonstrated the outstanding expertise of Dongguan’s refractive specialists and the strong comprehensive strength of the hospital’s refractive specialty.

Director Chen Xiaobei Shares Authoritative Clinical Insights and Wins the Prestigious SMILE pro White Horse Award

On April 19, the SMILE pro Special Seminar of Aier Eye Hospital Group concluded successfully in Shanghai. Bringing together core refractive surgery practitioners and research talents from all Aier Eye branches nationwide, the seminar focused on in-depth discussions over standardized clinical application of the new-generation SMILE pro, management of complex cases, and long-term clinical outcome evaluation.

As an invited keynote speaker, Director Chen delivered a speech themed New Technology: A New Engine for Refractive Development. Drawing on nearly 20 years of rich clinical experience and localized practical outcomes at Aier Eye Hospital Dongguan, she thoroughly interpreted the core value of technological upgrades of the new-generation robotic ReLEx SMILE pro. She analyzed the reasons behind the rapid popularity of this advanced technology in Dongguan from multiple perspectives, and systematically shared practical experience in the full-scale local implementation of cutting-edge technologies, including the establishment of standardized diagnosis and treatment systems, precise pre-operative evaluation, refined intra-operative operation, and comprehensive post-operative follow-up. In addition, she explored how technological innovation drives high-quality development of the refractive industry and future directions to make premium eye correction technologies accessible to more myopic patients.

With detailed, professional content, practical clinical experience and unique in-depth industry perspectives, Director Chen won high recognition from on-site experts, scholars and ophthalmology peers, fully reflecting her profound understanding and clinical leadership in cutting-edge refractive technologies.

Since the introduction of this technology in July 2025, it has gained widespread popularity in Dongguan for its core strengths of ultra-fast operation, intelligence and enhanced safety. To date, over 700 new-generation robotic SMILE pro procedures have been completed. The exceptional medical skills and professional services of Director Chen’s team have earned wide recognition among local citizens and even gained firm trust from international patients.

Furthermore, Director Chen’s team was honored with the SMILE pro White Horse Award for outstanding performance in the clinical application of new-generation SMILE technology, surgical quality control, patient satisfaction and academic promotion. This prestigious award serves as authoritative recognition of the team’s professional competence, standardized techniques and clinical achievements, and represents a powerful showcase of Dongguan’s refractive expertise on the international stage.

At the ZEISS HORIZON 2026 Asia-Pacific Ophthalmology Summit, Director Chen and her team stood out with leading clinical capabilities and standardized diagnosis and treatment results, claiming the SMILE pro White Horse Award and highlighting the professional caliber of Dongguan’s refractive industry.